MedWatch

Demant to divest hearing implant division to Cochlear

Hearing aid manufacturer Demant has announced it will sell its hearing implant business, Oticon Medical, to Cochlear for a total sum of DKK 850m (USD 121.5m). (Updated)

Photo: Demant / PR

On Wednesday, hearing aid manufacturer Demant has announced its intention to divest its hearing implant business, Oticon Medical, which was established in 2007, the company reports in a press release.

On the buying end will be Australian hearing firm Cochlear, which is already one of the world’s market leaders within hearing implants.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs